Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blake Gilks

Showing results (81-90 of 383) with videos related to

Pageof 39
Sort By:
The American Journal of Surgical Pathology|February 24, 2005
Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasmsEsther Elishaev, C Blake Gilks, Dianne Miller, et al.
Nature Reviews. Cancer|November 26, 2016
The disparate origins of ovarian cancers: pathogenesis and prevention strategiesAnthony N Karnezis, Kathleen R Cho, C Blake Gilks, et al.
Gynecologic Oncology Reports|June 16, 2015
Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgeryWen Yee Chay, Hugo M Horlings, Anna V Tinker, et al.
Gynecologic Oncology|February 22, 2005
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profilingC Blake Gilks, Barbara C Vanderhyden, Shirley Zhu, et al.
Histopathology|June 27, 2024
Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinomaElke E M Peters, Marisa R Nucci, C Blake Gilks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 17, 2008
The fibromatosis signature defines a robust stromal response in breast carcinomaAndrew H Beck, Inigo Espinosa, C Blake Gilks, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 13, 2012
It sounded like a good idea at the timeAlicia Tone, Jessica McAlpine, Sarah Finlayson, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2013
Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registryRola H Ali, Steve E Kalloger, Jennifer L Santos, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2023
PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic NeviSpencer D Martin, Karina C Martin, C Blake Gilks, et al.
Pageof 39

Showing results (81-90 of 383) with videos related to

Sort By:
Pageof 39
The American Journal of Surgical Pathology|February 24, 2005
Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasmsEsther Elishaev, C Blake Gilks, Dianne Miller, et al.
Nature Reviews. Cancer|November 26, 2016
The disparate origins of ovarian cancers: pathogenesis and prevention strategiesAnthony N Karnezis, Kathleen R Cho, C Blake Gilks, et al.
Gynecologic Oncology Reports|June 16, 2015
Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgeryWen Yee Chay, Hugo M Horlings, Anna V Tinker, et al.
Gynecologic Oncology|February 22, 2005
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profilingC Blake Gilks, Barbara C Vanderhyden, Shirley Zhu, et al.
Histopathology|June 27, 2024
Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinomaElke E M Peters, Marisa R Nucci, C Blake Gilks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 17, 2008
The fibromatosis signature defines a robust stromal response in breast carcinomaAndrew H Beck, Inigo Espinosa, C Blake Gilks, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 13, 2012
It sounded like a good idea at the timeAlicia Tone, Jessica McAlpine, Sarah Finlayson, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2013
Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registryRola H Ali, Steve E Kalloger, Jennifer L Santos, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2023
PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic NeviSpencer D Martin, Karina C Martin, C Blake Gilks, et al.
Pageof 39